Navigation Links
No Need for All-Day Patch to Treat 'Lazy Eye'
Date:9/14/2007

Just 3 hours per day helps kids see better, study finds

FRIDAY, Sept. 14 (HealthDay News) -- A new study could be great news for children with "lazy eye."

British researchers say youngsters may not need to wear an eye patch 12 hours a day, as is currently recommended, to treat the condition.

Instead, wearing the patch just three to four hours a day over a period of three months may do the trick to improve sight, the new study suggests.

"Lengthy durations of daily patching, which are incredibly burdensome on the child and their parents, are clinically unnecessary," said study co-author Merrick J. Moseley, a senior lecturer in the Department of Optometry and Visual Science at City University in London, England.

His team reported its findings in the Sept. 13 online edition of the British Medical Journal.

Lazy eye, or amblyopia, is caused by a disturbance to the vision pathways between the eyes and the brain, and is associated with blurred vision or crossed eyes. Studies have shown that patching can improve vision.

Although prior findings have found that patch use 12 hours a day is no better than six hours a day, many doctors have continued to prescribe more than six hours of patching daily.

To find out how well patching worked, Moseley's team studied 80 3- to 8-year-olds with amblyopia. The children were told to wear a patch for either six or 12 hours a day. The youngsters were also electronically monitored to see how long they actually wore their eye patch.

The team found that children prescribed six hours of eye patching a day did just as well as those prescribed 12 hours a day. "Moreover, monitoring showed that children wear their patches only for about half the time that they are prescribed," Moseley said.

"Children who actually patched 3 to 6 hours each day did just as well as those who patched 6 to 12 hours each day," Moseley said. However, "th
'/>"/>

Copyright©2007 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Beware of the oral patch! It could be cancer!!!
2. Emotional callers hamper speedy ambulance dispatch
3. FDA Approves Birth Control Skin Patch
4. FDA approves Watson Pharmaceuticals Oxytrol patch
5. Capsaicin patches help reduce post-shingles pain
6. Estrogen Patch is Safer than Pills for Heart
7. Painkilling Patch As Effective As Intravenous Delivery Systems
8. Testosterone patch for women Rejected For safety Reasons
9. Fentanyl Narcotic Pain Patch under Scrutiny
10. Testosterone Patches Found To Increase Sexual Desire In Menopausal Women
11. Will you be willing to patch up your vertebrae with cement?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...n. 8 New York City Mayor Michael R...Education Day" and presented a proclamation to Ilc...ucation Association) and developer of Brain Educat...to enhance health, well-being, and mental ability ... leader regarding the power of individuals to chan...
(Date:1/8/2009)...Va., Jan. 8 Today, the ...along with several national leadership organizatio...ciples of hospice care and protection of the Medic...gether in sharing this unified message about end-o...e and Palliative Medicine, Hospice and Palliative ...
(Date:1/8/2009)...ugar sitting on the surface of cancer cells are ke...th treating and stopping the spread of certain typ...state, breast, ovarian and lung, among others. Ar...e Gateway for Cancer Research, an Illinois-based p...ranco, M.D., Ph.D., and her co-workers at the Moor...
(Date:1/8/2009)...ts Prenatal Solution Key Factor in Decision for Fl...LANDO, Fla., Jan. 8 Alls...LC, one of the largest multi-specialty group pract...the Allscripts Enterprise(TM) Electronic Health Re...ians in 18 offices across Central Florida. , ,...
Breaking Medicine News(10 mins):Health News:NYC Mayor Michael R. Bloomberg Declares January 8th 'IBREA Brain Education Day' 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 2Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 3Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 4Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 5Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 6Health News:National End-of-Life Organizations Release Consensus Statement on Hospice, the Medicare Hospice Benefit, and Key Issues for the Future 7Health News:Novel prostate cancer vaccine taking aim at cancer cell 'sweet spot' 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 2Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 3Health News:Physician Associates, LLC Selects Allscripts Electronic Health Record to Connect and Automate 80 Physicians 4
...d test called Cystatin-C for predicting cardiovasc...malfunction. Earlier test that was used was creati...e more effective and better predictor than the ear...hree types of cardiovascular risks: low, medium an...
...erial infection of the lungs, says a study publish...rchers had studied persons of age between 2 to 49 ...rsons with invasive pneumococcal disease, 10 perso...as controls. Asthma was defined by the study as pr...
...ity Baptist Medical Center, US, have found that lo...hildren with cancer, and thus limits the side effe...oked into the chemotherapy given to children suffe...(ALL). Patients suffering from for this type of ch...
...accine for treating Alzheimer’s disease may be abl... use the bodies own immunity to resist the onset a...t affect people above the age of 40 years. The fi...ls which began some time back, was when scientists...
Other Medicine News:
(Date:1/7/2009)... , FREDERICK, Md., Jan. 7 ImQue...bmission of an IND application to the Food and Dru... for their lead pyrimidinedione HIV inhibitor IQP-... studies in the first quarter of 2009. IQP-0410 is...marily acts as a nonnucleoside reverse transcripta...
(Date:1/6/2009)... , Program Expands on Successful Results from p... Jan. 7 Vital Therapies, Inc. (VTI...ease, today announced patient enrollment has begun... 2 clinical trial that will study the Extracorpore...atients with Acute Liver Failure (ALF) under three...
(Date:1/6/2009)... , ROCKVILLE, Md., Jan. 6 /PRNewswire-USNewswir...utical company focused on diseases of epidemic pot...candidate for the treatment of tuberculosis (TB), ...wly awarded clinical program contract to Dynport V...e contract, awarded by the National Institute of A...
(Date:1/5/2009)... , SAN DIEGO, Jan. 5 Cylene Pha... a Phase I clinical trial of its oral CK2 protein ...ed solid tumors, Castleman,s disease, or multiple ...calating trial are determination of safety, tolera... appropriate dose for Phase II trials. In addition...
Breaking Medicine Technology:ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 2Cylene Pharmaceuticals Initiates Phase I Trial With CX-4945 -Breakthrough First-in Class Inhibitor of CK2 3Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 1Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 2Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 3Greenway Medical Technologies EHR Solution PrimeSuite Wins Three Best in KLAS Awards 32167 4Sage Software Healthcare Appoints Kathleen Henry Senior Vice President Customer Service 32165 1Sage Software Healthcare Appoints Kathleen Henry Senior Vice President Customer Service 32165 2Immune System Works Better at Night 32164 1Immune System Works Better at Night 32164 2Later School Start Time Cuts Teens Car Crash Risk 32162 1Later School Start Time Cuts Teens Car Crash Risk 32162 2Later School Start Time Cuts Teens Car Crash Risk 32162 3
...)--Jun 4, 2007 - Introgen Therapeutics, Inc.,(NASD... today,reported updated Phase 2 data demonstrating...umor responses and increased,survival following AD...us cell carcinoma of the head and neck. The data (... meeting of the American,Society of Clinical Oncol...
...se 2 Clinical Data Published at the American,Socie...GO, June 04, 2007 /PRNewswire-FirstCall/ -- Pharmi...m its Phase II,multi-center clinical study of Amr...nthracycline currently in development,for the trea...dicate favorable interim results in terms of respo...
Other Medicine Technology:Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 2Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 3Introgen Reports Updated Phase 2 Advexin Data Correlating Improved,Survival, Tumor Responses and Predictive p53 Biomarker 4Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 2Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 3Pharmion's Amrubicin Shows Encouraging Results Compared to Standard,of Care in Second Line Treatment of Small Cell Lung Cancer 4
The 15 and 18 Sony Flat Screen Monitors with articulating arm can be used in conjunction with existing surgical monitors or as replacements.
Colour video monitors.
The A3 3-Chip Camera includes digital processing, seamless autoshutter, industry-leading reliability, white balance with memory function, ease of operation, and a 2 year warranty.
Camera and light source in one compact "Plug-and-Play" device.
Medicine Products: